Phase II Trial of Gemcitabine and nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation
The Lancet Oncology , Volume 17 , Issue 10 , 1396 - 1408
osteosarcoma
Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
13:35
סגור לתגובות על Pediatric cancer-pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
The Lancet Oncology , Volume 17 , Issue 10 , 1396 - 1408
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
16:54
סגור לתגובות על Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
The Lancet Oncology , Volume 17 , Issue 10 , 1396 - 1408
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
16:47
סגור לתגובות על Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Journal of Clinical Oncology 2015 33:20, 2279-2287
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
16:50
סגור לתגובות על EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
Annals of Oncology, Volume 26, Issue 2, 1 February 2015, Pages 407–414
